Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bioasis Technologies Inc. > XB3 and its cost in the health care system?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(13)
•••
Comment by narmacon Apr 24, 2022 1:17pm
92 Views
Post# 34627364

RE:RE:XB3 and its cost in the health care system?

RE:RE:XB3 and its cost in the health care system?Thanks JD,,yes I would think that at commecialization we would reduce the over all costs substantially. It was just something which I thought of earlier but it kept escaping me when time came to discuss. It would ebawesome to have the team disuss some of these points ina presentation. Hope we start seeing some news being released on data points etc.

My cupboard is also starting to suffer with these prices we are seeing!!...and anticipated to steadilly increase for the next 18 months or so....ugghhhh!!!,,,,Bring it on DrDR!!! We are do!!!!!!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities